GLD News 121.65 09/03/2014 04:56:38 SPDR Gold (GLD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
SPDR Gold (GLD) 121.65 $GLD

SmarTrend Watching for Potential Rebound in Shares of SPDR Gold Trust After 1.78% Loss
Comtex SmarTrend(R) - Tue Sep 02, 3:39PM CDT
SPDR Gold Trust (NYSE:GLD) traded in a range yesterday that spanned from a low of $121.43 to a high of $122.08. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $123.25 on volume of 10.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SPDR Gold Trust Set to Possibly Rebound After Yesterday's Selloff of 1.78%
Comtex SmarTrend(R) - Tue Sep 02, 3:39PM CDT
SPDR Gold Trust (NYSE:GLD) traded in a range yesterday that spanned from a low of $121.43 to a high of $122.08. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $123.25 on volume of 10.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Take a Chance on S&P 500, Since Weak Volume Can Still Work
at The Street - Tue Sep 02, 3:30PM CDT
September isn’t usually the best month of the year, but neither is August -- and August was fantastic.

Stock Market Today: Stocks End Mixed Despite Gains in Manufacturing, Construction
at The Street - Tue Sep 02, 3:18PM CDT
U.S. stock indices perform mixed as the 'worst' month of the year begins for markets.

Stock Market Today: Stocks Dip Despite Gains in Manufacturing, Construction
at The Street - Tue Sep 02, 12:21PM CDT
U.S. stock markets dip Tuesday afternoon as investors return from the U.S. Labor Day weekend to begin September, the 'worst' month of the year for markets.

ISM Manufacturing Surges to 3 Year High - Real Time Insight
Neena Mishra - ZACKS - Tue Sep 02, 11:05AM CDT
Manufacturing expands rapidly propelled by new orders and production.

Stock Market Today: Futures Rise, S&P 500 Sits Near All-Time Highs to Begin September
at The Street - Tue Sep 02, 6:42AM CDT
U.S. stock index futures are drifting higher Tuesday as the market returns from the U.S. labor day weekend to begin September, historically the 'worst' month of the year.

3 Reasons Market Vectors Gold Miners ETF (GDX) Could Fall
Jason Hall, The Motley Fool - Motley Fool - Thu Aug 28, 3:19PM CDT
Gold mining is expensive and hard, and gold miners have zero pricing power. A week or so ago, I wrote an article that listed three reasons to buy Market Vectors Gold Miners ETF  . It's important to understand that gold went on an unprecedented...

Gold Participation and Income Fund Announces Semi-Annual End Results
Marketwire - Thu Aug 28, 3:04PM CDT
Gold Participation and Income Fund (the "Fund"(TSX: GPF.UN) announces results for the six months ended June 30, 2014. Increase in net assets attributable to equity holders amounted to $1.0 million or $0.97 per unit. Net assets attributable to equity holders as at June 30, 2014 were $6.1 million or $6.24 per unit. Cash distributions to equity holders in the amount of $0.2 million or $0.20 per unit were paid during the period.

3 ETFs in Focus on Escalating Russia/Ukraine Tensions - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Aug 25, 1:00PM CDT
These ETFs look to be in focus for the coming days, especially in the wake of escalating Russia-Ukraine tensions.

Gold and Oil on the Verge of Something Big – but Heroes Rarely Win
at The Street - Mon Aug 25, 9:04AM CDT
The fact is that gold and gold stocks are still clearly in a bear market. Just look at the 200 day moving averages.

Jim Cramer's 'Mad Money' Recap: Cramer Opens His Playbook
at The Street - Fri Aug 22, 6:00PM CDT
One thing America's education system does not teach is financial literacy, says 'Professor' Cramer.

Critical Alerts For Advanced Micro Devices, SPDR Gold Trust, Express Scripts, Qualcomm and Urban Outfitters Released By InvestorsObserver
PR Newswire - Fri Aug 22, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AMD, GLD, ESRX, QCOM and URBN.

Watch for SPDR Gold Trust to Potentially Rebound After Falling 1.08% Yesterday
Comtex SmarTrend(R) - Thu Aug 21, 3:41PM CDT
SPDR Gold Trust (NYSE:GLD) traded in a range yesterday that spanned from a low of $122.45 to a high of $123.24. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $123.88 on volume of 8.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of SPDR Gold Trust to Potentially Rebound after Yesterday's 1.08% Sell Off
Comtex SmarTrend(R) - Thu Aug 21, 3:40PM CDT
SPDR Gold Trust (NYSE:GLD) traded in a range yesterday that spanned from a low of $122.45 to a high of $123.24. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $123.88 on volume of 8.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Economic Recovery Doesn't Satisfy Fed as Stocks Soar Higher
at The Street - Thu Aug 21, 10:14AM CDT
Low inflation and slack in the labor market has kept policymakers dovish, leading to strength in U.S. equities and in high-beta sectors.

Corn Futures in Focus: Can the Slump Continue? - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Mon Aug 18, 5:32PM CDT
What is the near term outlook for corn prices?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading